Biological: Solrikitug low dose clinical trials

A Study to Evaluate Solrikitug in Participants With COPD (ZION)

This study is testing a new medicine, Solrikitug, for people with a lung condition called COPD. Researchers want to see if different doses are safe and how they affect the body and COPD symptoms compared to a dummy medicine.